Unique ID issued by UMIN | UMIN000025847 |
---|---|
Receipt number | R000029721 |
Scientific Title | Endobiliary Radiofrequency Ablation Using a New Catheter for Malignant Biliary Strictures: A Prospective Multicenter Study |
Date of disclosure of the study information | 2017/01/25 |
Last modified on | 2017/01/25 20:40:31 |
Endobiliary Radiofrequency Ablation Using a New Catheter for Malignant Biliary Strictures: A Prospective Multicenter Study
Endobiliary radiofrequency ablation for malignant biliary strictures
Endobiliary Radiofrequency Ablation Using a New Catheter for Malignant Biliary Strictures: A Prospective Multicenter Study
Endobiliary radiofrequency ablation for malignant biliary strictures
Asia(except Japan) |
Malignant biliary strictures by bile duct cancer, gallbladder cancer, or pancreatic cancer
Hepato-biliary-pancreatic medicine |
Malignancy
NO
The aim of this study is to evaluate the safety and efficacy of endobiliary radiofrequency ablation (RFA) by using a new catheter in patients with malignant biliary strictures.
Safety,Efficacy
The incidence of early adverse events within 30 days after endobiliary radiofrequency such as hemobilia, bile duct perforation, pancreatitis, bleeding, cholangitis, perforation, or cholecystitis.
Late adverse events after 30 days after endobiliary radiofrequency, stent patency of biliary metallic stent after endobiliary radiofrequency ablation, and patient survival after endobiliary radiofrequncy ablation.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Other |
Endobiliary radiofrequency ablation by using a new catheter and biliary metallic stenting through ERCP
19 | years-old | <= |
80 | years-old | >= |
Male and Female
1) More than 19 in age
2) Extrahepatic malignant biliary stricture that was histophathologically or clinically confirmed
3)Unresectable or inoperable due to comorbidity or refusal of operation
4) More than 3 months of predictive survival
1) Contraindications for ERCP
2) Uncontrolled coagulopathy: PT-INR > 1.5 (normal 0.85 - 1.25) or platelet count < 60,000/mm3 (normal 150,000 - 450,000/mm3)
3) Previously operation of bile duct
4) Impossible to access to the ampulla of Vater or failed selective biliary cannulation
5) Pregnant or breastfeeding women
6) Refusal to the study
100
1st name | |
Middle name | |
Last name | Hyun Jong Choi |
SoonChunHyang University School of Medicine
Digestive Disease Center and Research Institute, Department of Internal Medicine
170 Jomaru-ro, Wonmi-gu, Bucheon 14584
+82-32-621-5211
joseph@schmc.ac.kr
1st name | |
Middle name | |
Last name | Hyun Jong Choi |
SoonChunHyang University School of Medicine
Digestive Disease Center and Research Institute, Department of Internal Medicine
170 Jomaru-ro, Wonmi-gu, Bucheon 14584
+82-32-621-5211
joseph@schmc.ac.kr
Digestive Disease Center and Research Institute, Department of Internal Medicine, SoonChunHyang University School of Medicine
Digestive Disease Center and Research Institute, Department of Internal Medicine, SoonChunHyang University School of Medicine
Self funding
NO
2017 | Year | 01 | Month | 25 | Day |
Unpublished
2016 | Year | 03 | Month | 04 | Day |
2016 | Year | 03 | Month | 10 | Day |
2017 | Year | 01 | Month | 25 | Day |
2017 | Year | 01 | Month | 25 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029721
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |